Literature DB >> 8524248

CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation.

M E Crooks1, D R Littman, R H Carter, D T Fearon, A Weiss, P H Stein.   

Abstract

T-cell activation involves two distinct signal transduction pathways. Antigen-specific signaling events are initiated by T-cell receptor recognition of cognate peptide presented by major histocompatibility complex molecules. Costimulatory signals, which are required for optimal T-cell activation and for overcoming the induction of anergy, can be provided by the homodimeric T-cell glycoprotein CD28 through its interaction with the counterreceptors B7-1 and B7-2 on antigen-presenting cells. Ligation of CD28 results in its phosphorylation on tyrosines and the subsequent recruitment and activation of phosphatidylinositol 3-kinase (PI 3-kinase). It has been suggested that the induced association of CD28 and PI 3-kinase is required for costimulation. We report here that ligation of CD19, a heterologous B-cell receptor that also associates with and activates PI 3-kinase upon ligation, failed to costimulate interleukin-2 production. Moreover, pharmacological inhibition of PI 3-kinase activity failed to block costimulation mediated by CD28. By mutational analysis, we demonstrate that disruption of PI 3-kinase association with CD28 also did not abrogate costimulation. These results argue that PI 3-kinase association with CD28 is neither necessary nor sufficient for costimulation of interleukin-2 production. Finally, we identify specific amino acid residues required for CD28-mediated costimulatory activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524248      PMCID: PMC230936          DOI: 10.1128/MCB.15.12.6820

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase.

Authors:  D A Tuveson; R H Carter; S P Soltoff; D T Fearon
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

3.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.

Authors:  A Weiss; B Manger; J Imboden
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

Review 5.  Cell surface molecules and early events involved in human T lymphocyte activation.

Authors:  A Weiss; J B Imboden
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

6.  The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.

Authors:  P H Stein; J D Fraser; A Weiss
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

8.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

Authors:  T Lindstein; C H June; J A Ledbetter; G Stella; C B Thompson
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

9.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

10.  A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.

Authors:  D B Durand; M R Bush; J G Morgan; A Weiss; G R Crabtree
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  12 in total

1.  Lack of costimulation by both sphingomyelinase and C2 ceramide in resting human T cells.

Authors:  D O'Byrne; D Sansom
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

Review 2.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

3.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

4.  Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells.

Authors:  Niklas Engels; Lars Morten König; Christina Heemann; Johannes Lutz; Takeshi Tsubata; Sebastian Griep; Verena Schrader; Jürgen Wienands
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

5.  Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.

Authors:  Peilong Lai; Jianyu Weng; Zesheng Lu; Rong Guo; Chenwei Luo; Suijing Wu; Wei Ling; Suxia Geng; Xin Du
Journal:  DNA Cell Biol       Date:  2011-06-17       Impact factor: 3.311

6.  Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

Authors:  S Gibson; K Truitt; Y Lu; R Lapushin; H Khan; J B Imboden; G B Mills
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 7.  CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Authors:  J M Slavik; J E Hutchcroft; B E Bierer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 8.  CD28: a signalling perspective.

Authors:  S G Ward
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

Review 9.  Models of T cell anergy: is there a common molecular mechanism?

Authors:  R H Schwartz
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  Itk negatively regulates induction of T cell proliferation by CD28 costimulation.

Authors:  X C Liao; S Fournier; N Killeen; A Weiss; J P Allison; D R Littman
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.